News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
516,167 Results
Type
Article (30287)
Company Profile (277)
Press Release (485504)
Multimedia
Podcasts (148)
Webinars (17)
Section
Business (156205)
Career Advice (440)
Deals (24821)
Drug Delivery (113)
Drug Development (66953)
Employer Resources (67)
FDA (12475)
Job Trends (10023)
News (239143)
Policy (19262)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (3)
2027 Genetown Standard (5)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (6)
Academia (1878)
Academic (1)
Accelerated approval (51)
ADA (45)
Adcomms (22)
Allergies (175)
Alliances (37077)
ALS (223)
Alzheimer's disease (1739)
Antibody-drug conjugate (ADC) (574)
Approvals (13103)
Artificial intelligence (701)
ASCO (293)
Autoimmune disease (371)
Automation (56)
Bankruptcy (179)
Best Places to Work (8458)
BIO (68)
Biologics (3)
BIOSECURE Act (15)
Biosimilars (232)
BioSpace Insights (126)
Biotechnology (201)
Bladder cancer (195)
Brain cancer (73)
Breast cancer (752)
Cancer (6090)
Cardiovascular disease (519)
Career advice (411)
Career pathing (23)
CAR-T (368)
CDC (15)
Celiac Disease (1)
Cell therapy (989)
Cervical cancer (48)
Clinical research (59931)
Collaboration (2318)
Commercialization (8)
Company closure (4)
Compensation (1232)
Complete response letters (87)
COVID-19 (2129)
CRISPR (121)
C-suite (1275)
Cystic fibrosis (149)
Data (8423)
Decentralized trials (1)
Denatured (52)
Depression (165)
Dermatology (107)
Diabetes (636)
Diagnostics (5478)
Digital health (60)
Diversity (9)
Diversity, equity & inclusion (19)
Drug discovery (395)
Drug pricing (101)
Drug shortages (19)
Duchenne muscular dystrophy (336)
Earnings (56004)
Editorial (47)
Employer branding (12)
Employer resources (62)
Events (89442)
Executive appointments (1110)
FDA (16337)
Fibrodysplasia Ossificans Progressiva (11)
Friedreich's ataxia (25)
Frontotemporal dementia (37)
Funding (1786)
Gene editing (261)
Generative AI (64)
Gene therapy (772)
GLP-1 (979)
Government (2614)
Grass and pollen (8)
Guidances (351)
Healthcare (13072)
Hematology (194)
HIV (88)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (128)
Immunology and inflammation (303)
Immuno-oncology (104)
Indications (224)
Infectious disease (2446)
Inflammatory bowel disease (221)
Inflation Reduction Act (11)
Influenza (118)
Intellectual property (308)
Interviews (55)
IPO (12197)
IRA (24)
Job creations (1936)
Job search strategy (351)
JPM (55)
Kidney cancer (24)
Labor market (62)
Layoffs (407)
Leadership (23)
Legal (3239)
Licensing (12)
Liver cancer (89)
Longevity (34)
Lung cancer (816)
Lymphoma (466)
Machine learning (58)
Management (18)
Manufacturing (1080)
Marketing (13)
MASH (210)
Medical affairs (1)
Medical device (9443)
Medtech (9584)
Mergers & acquisitions (13879)
Metabolic disorders (1544)
mRNA (228)
Multiple sclerosis (194)
NASH (18)
Neurodegenerative disease (471)
Neuropsychiatric disorders (106)
Neuroscience (3350)
Neurotech (1)
NextGen: Class of 2026 (3678)
Non-profit (2719)
Now hiring (57)
Obesity (680)
Opinion (214)
Ovarian cancer (230)
Pain (221)
Pancreatic cancer (340)
Parkinson's disease (391)
Partnered (31)
Patents (600)
Patient recruitment (800)
Peanut (62)
People (45057)
Pharmaceutical (47)
Pharmacy benefit managers (10)
Phase 1 (19122)
Phase 2 (26366)
Phase 3 (19837)
Pipeline (10358)
Policy (185)
Postmarket research (1824)
Preclinical (7917)
Press Release (60)
Prostate cancer (326)
Psychedelics (77)
Radiopharmaceuticals (354)
Rare diseases (1228)
Real estate (3718)
Recruiting (29)
Regulatory (18789)
Reports (36)
Research institute (1940)
Resumes & cover letters (49)
Rett syndrome (48)
RNA editing (32)
RSV (64)
Schizophrenia (182)
Series A (321)
Series B (228)
Service/supplier (3)
Sickle cell disease (129)
Special edition (24)
Spinal muscular atrophy (159)
Sponsored (45)
Startups (2747)
State (1)
Stomach cancer (12)
Supply chain (111)
Tariffs (40)
The Weekly (94)
Vaccines (922)
Venture capital (119)
Weight loss (415)
Women's health (121)
Worklife (6)
Date
Today (85)
Last 7 days (336)
Last 30 days (2115)
Last 365 days (26809)
2026 (17623)
2025 (26506)
2024 (30012)
2023 (33571)
2022 (43652)
2021 (46556)
2020 (42529)
2019 (32115)
2018 (24021)
2017 (24457)
2016 (22855)
2015 (26739)
2014 (19948)
2013 (15741)
2012 (16545)
2011 (16193)
2010 (14920)
Location
Africa (463)
Alabama (87)
Alaska (4)
Arizona (199)
Arkansas (13)
Asia (33150)
Australia (5730)
California (12718)
Canada (3447)
China (1661)
Colorado (524)
Connecticut (518)
Delaware (428)
Europe (75050)
Florida (1789)
Georgia (429)
Hawaii (5)
Idaho (37)
Illinois (952)
India (120)
Indiana (589)
Iowa (19)
Japan (641)
Kansas (121)
Kentucky (28)
Louisiana (42)
Maine (45)
Maryland (1449)
Massachusetts (9730)
Michigan (355)
Minnesota (580)
Mississippi (4)
Missouri (132)
Montana (32)
Nebraska (16)
Nevada (121)
New Hampshire (67)
New Jersey (3449)
New Mexico (30)
New York (3312)
North Carolina (1592)
North Dakota (10)
Northern California (6503)
Ohio (365)
Oklahoma (22)
Oregon (34)
Pennsylvania (2511)
Puerto Rico (29)
Rhode Island (39)
South America (653)
South Carolina (32)
Southern California (5062)
Tennessee (172)
Texas (1867)
United States (44527)
Utah (274)
Virginia (295)
Washington D.C. (64)
Washington State (1043)
West Virginia (2)
Wisconsin (136)
Wyoming (2)
516,167 Results for "global blood therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Blood Cancer United Launches 2026 Light The Night Season During Blood Cancer Awareness Month
August 25, 2026
·
2 min read
Press Releases
BioMark’s Metabolomics Platform Captures Global Scientific Interest Following Publications Demonstrating Superior Diagnostic Performance and Cost Efficiency for Liquid Biopsy
Five peer-reviewed studies published in nine months independently confirm high accuracy, robust panel optimization, and commercial viability of BioMark’s blood-based assay.
August 25, 2026
·
4 min read
Press Releases
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
August 4, 2026
·
1 min read
Press Releases
Contineum Therapeutics to Present at the 2026 Morgan Stanley Global Healthcare Conference
August 25, 2026
·
1 min read
Rare diseases
Silence causes uproar in rare blood cancer space as data sets high bar for competitors
The mid-stage win of Silence Therapeutics’ siRNA drug in polycythemia vera validates the therapeutic approach of similar assets in development—but also sets a high standard for therapies from Takeda, Agios and Disc Medicine.
August 11, 2026
·
2 min read
·
Tristan Manalac
Layoffs
ADC Therapeutics lays off staff after 27 patient deaths mar Zynlonta readout
After 27 deaths were reported in a group receiving its blood cancer drug, ADC Therapeutics is downsizing, implementing layoffs for about 30 workers.
June 24, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Foundation for Angelman Syndrome Therapeutics Announces Agreement with Apertura Gene Therapy for Access to Blood-Brain Barrier-Crossing Capsid
August 5, 2026
·
3 min read
Approvals
AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer
Decnupaz is the first antibody-drug conjugate for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare and aggressive blood cancer.
May 28, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Actimed Therapeutics Reacquires Global Rights to S-oxprenolol, Broadening Pipeline Opportunity
August 6, 2026
·
3 min read
Press Releases
Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference
August 25, 2026
·
4 min read
1 of 51,617
Next
